C225 (cetuximab)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for C225 (cetuximab), covering 2011-03-25 to 2011-03-25. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Study of Concurrent C225, Cisplatin and Radiation in Stage IV Squamous Cell Carcinoma of the Head and Neck [Phase 2]